A carregar...
Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research
Despite surgical resection and adjuvant chemoradiation, survival for glioblastoma remains poor. Because of the dismal prognosis, attention has shifted to alternative adjuvant treatment modalities. Although traditionally limited to systemic malignancies (melanoma, lung and colon cancer), the field of...
Na minha lista:
| Publicado no: | Cureus |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cureus
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5910011/ https://ncbi.nlm.nih.gov/pubmed/29692957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.2130 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|